All Articles

As skin cancer rates climb, a non-profit is moving beyond awareness by installing 100+ free sunscreen dispensers. Is this tangible action the future of public health?

As Abigail Buckwalter takes the helm at Ocean Spray, the iconic cooperative bets on her global CPG expertise. Can she drive growth while honoring its farmer-owned roots?

Federal, provincial, and municipal leaders converge in Montreal. Is this a landmark shift in housing policy or just another press conference? We dissect the stakes.

Hemlo Mining's appointment of capital markets veteran Eva Koci is more than a new face on the board. It's a strategic move to fortify governance and fund a new era of growth.

London hosts the ARC conference, a powerful conservative summit aiming to rewrite the rules on energy, industry, and Western identity. What is their plan?

A new platform, Wedoany, claims to connect 74 million industrial firms. Can its AI and massive database truly streamline the fragmented world of global engineering?

A new alliance between Geely, WeRide, and Kwoon Chung targets the world's RHD markets with a purpose-built robotaxi, making Hong Kong the global launchpad.

Sweeping reforms to Canada’s bail and sentencing laws are now in effect, introducing a modernized legal toolkit designed to curb violent crime and protect critical infrastructure.

Traditional life milestones are vanishing. As Canadians forge new paths, a silent financial risk emerges, prompting a critical look at our protection.

Canada's only national non-profit insurer is betting $200M on a radical idea: that business growth and social good aren't just compatible, they're codependent.

S&P upgrades Bladex to 'BBB+', but the real story is how the bank built a fortress of stability, offering a rare model of resilience for Latin America.

The Iress-BitDelta Pro partnership equips the UAE platform for a major push into equities, reflecting a broader trend of FinTech maturation in the region.

A startup just raised $5M for an AI that teaches cells to be better factories. It's a glimpse into a future of cheaper, faster advanced medicines for all.

A new partnership between AI innovator Rokid and optical giant Krys isn't just about selling smart glasses; it's a strategic blueprint for making them essential.

With FDA clearance for its first-in-class remyelination drug, Scottish biotech Pheno Therapeutics is moving beyond inflammation to repair neurological damage.

As Hisense's logos flash at the World Cup, it's not just an ad play. It's a calculated strategy to conquer the global market, one living room at a time.

Over half of all brands have deployed advanced AI, yet it's stuck on simple tasks. A new report reveals why data fragmentation is costing them billions.

A new enzyme blend for dogs boasts a 92% success rate in a clinical trial. We analyze the data and what it means for the pet supplement industry's future.

As financial titans converge in Baku, Azerbaijan’s insurance sector is becoming a crucial testbed for digital resilience and managing catastrophic risk.